tradingkey.logo
tradingkey.logo
Search

Gain Therapeutics Inc

GANX
Add to Watchlist
1.040USD
-0.040-3.70%
Close 11-13 16:00(ET)
45.39MMarket Cap
LossP/E TTM

Today

-3.70%

5 Days

+0.97%

1 Month

-21.80%

6 Months

-40.57%

Year to Date

-67.70%

1 Year

-63.25%

Key Figures

1.120Open
1.140High
18.62KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
1.080Prev. Close
1.010Low
19.26KTurnover
LossP/E Static
4.51P/B
0.00%Div Yield TTM
-139.91%ROA
4.34052wk High
0.06Volume Ratio
-20.41MNet Profit
43.64MShares
-0.5864EPS TTM
0.17Beta
-214.69%ROE
0.94052wk Low
12.04%Amplitude
100.00%Gross Margin
45.39MMarket Cap
4.74Reward/Risk
6.44%Risk Rate
More news coming soon, stay tuned...

Gain Therapeutics Inc's Score

-0.03vs previous score
Forecast8.80
Financial Health6.75
Technical4.99
Valuation Dimensions6.27
Institutional Confidence3.00
Risk Assessment2.72

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
7.250Target Price
+541.59%Upside Space
Current Rating2026-112026-102026-092026-082026-072026-062026-052026-04
Strong Buy22222222
Buy33333333
Hold00000000
Sell00000000
Strong Sell00000000

Gain Therapeutics Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.11/-0.14
Revenue / Forecast
--/0.00

Gain Therapeutics Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolGANX
Number of employees23
CountryUnited States of America

Ownership

ShareholdersProportion
Marshall Wace LLP3.90%
Potomac Capital Management Inc.2.37%
Islam (Khalid)2.18%
Edward Jones1.65%
Shareholder TypesProportion
Investment Advisor7.17%
Investment Advisor/Hedge Fund5.78%
Hedge Fund4.77%
Research Firm2.59%

FAQs

What is the current price of Gain Therapeutics Inc (GANX)?

The current price of Gain Therapeutics Inc (GANX) is 1.04.

What is the symbol of Gain Therapeutics Inc?

The ticker symbol of Gain Therapeutics Inc is GANX.

What is the 52-week high of Gain Therapeutics Inc?

The 52-week high of Gain Therapeutics Inc is 4.34.

What is the 52-week low of Gain Therapeutics Inc?

The 52-week low of Gain Therapeutics Inc is 0.94.

What is the market capitalization of Gain Therapeutics Inc?

The market capitalization of Gain Therapeutics Inc is 45.39M.

Is Gain Therapeutics Inc (GANX) currently rated as Buy, Hold, or Sell?

According to analysts, Gain Therapeutics Inc (GANX) has an overall rating of Buy, with a price target of 7.25.

What is the Earnings Per Share (EPS TTM) of Gain Therapeutics Inc (GANX)?

The Earnings Per Share (EPS TTM) of Gain Therapeutics Inc (GANX) is -0.59.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.